GlassScriptPhysician profile
Heather S Travis
NPI 1386692960
$2,320.18
in general payments reported to CMS, 2019-2025
42 companies · $29.74 in 2025
The $29.74 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $298 · 2023: $237 · 2024: $1,639 · 2025: $29.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,906.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $489.96 | 2022-2025 | |
| Lilly USA, LLC | $241.61 | 2021-2024 | Reyvow, Emgality, Mounjaro |
| Pfizer INC. | $165.66 | 2021-2024 | |
| Lundbeck LLC | $132.49 | 2024 | Vyepti, Rexulti |
| Novo Nordisk INC | $81.01 | 2022-2023 | Ozempic, Rybelsus |
| Ucb, INC. | $78.46 | 2024 | Briviact, Rystiggo |
| Kyowa Kirin, INC. | $66.78 | 2024 | Nourianz |
| Biohaven Pharmaceutical Holding Company LTD. | $66.70 | 2022 | |
| Nevro Corp. | $57.82 | 2024 | Senza |
| Merz Pharmaceuticals, LLC | $54.37 | 2024 | Xeomin |
| Abbott Laboratories | $52.11 | 2023-2024 | Freestyle Libre 3 |
| Catalyst Pharmaceuticals, INC. | $51.58 | 2024 | |
| Argenx US, INC. | $49.89 | 2024 | Vyvgart Hytrulo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.96 | 2021-2022 | |
| Genentech USA, INC. | $47.20 | 2021-2024 | Ocrevus |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $46.36 | 2024 | Tysabri, Vumerity, Avonex |
| Csl Behring | $45.27 | 2024 | Hizentra |
| Sandoz INC. | $42.78 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $35.74 | 2024 | Austedo Xr |
| Amneal Pharmaceuticals LLC | $28.52 | 2024 | Rytary |
| Emd Serono, INC. | $26.72 | 2024 | |
| Tanabe Pharma America, INC. | $26.61 | 2024 | |
| Eisai INC. | $23.88 | 2024 | |
| Octapharma USA, INC. | $23.55 | 2024 | Panzyga |
| Neurelis, INC. | $22.70 | 2024 | Valtoco |
| Neos Therapeutics, LP | $22.17 | 2023 | Adzenys Xr-Odt |
| Otsuka America Pharmaceutical, INC. | $22.16 | 2023 | Jynarque |
| Scilex Pharmaceuticals INC. | $21.66 | 2024 | |
| Sanofi Pasteur INC. | $21.55 | 2023 | |
| Lifescan, INC. | $21.32 | 2022 | |
| Grifols USA, LLC | $19.75 | 2024 | Gamunex-C |
| Sk Life Science, INC. | $19.27 | 2024 | |
| Janssen Pharmaceuticals, INC | $19.23 | 2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $18.67 | 2024 | Ultomiris |
| Sumitomo Pharma America, INC. | $18.43 | 2023 | Gemtesa |
| Medtronic, INC. | $18.36 | 2024 | Percept PC Brainsense |
| Exact Sciences Corporation | $18.18 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $17.60 | 2023 | Shingrix, Arexvy |
| Insulet Corporation | $15.39 | 2022 | |
| Currax Pharmaceuticals LLC | $13.96 | 2024 | Onzetra Xsail |
| Aucta Pharmaceuticals, INC. | $12.88 | 2024 | Motpoly Xr |
| Philips North America LLC | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Travis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.